Zeke Capital Advisors, LLC Bria Cell Therapeutics Corp. Transaction History

Zeke Capital Advisors, LLC

  • $1.53 Billion
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.89 - $6.57 $130,050 - $295,650
-45,000 Closed
0 $0
Q1 2021

Apr 21, 2021
BUY
$3.15 - $6.17 $141,750 - $277,650
45,000 New
45,000 $174,000

Others Institutions Holding BCTX

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About BriaCell Therapeutics Corp.

BCTX Quotes by TradingView
  • Ticker BCTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,518,000
  • Market Cap $11.8M
  • Description
  • BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...
More about BCTX
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email